Cargando…
Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases
Inhibition of bacterial virulence is believed to be a new treatment option for bacterial infections. In the present study, we tested dipicolylamine (DPA), tripicolylamine (TPA), tris pyridine ethylene diamine (TPED), pyridine and thiophene derivatives as putative inhibitors of the bacterial virulenc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746695/ https://www.ncbi.nlm.nih.gov/pubmed/35011288 http://dx.doi.org/10.3390/molecules27010056 |
_version_ | 1784630650712621056 |
---|---|
author | Rahman, Fatema Wushur, Imin Malla, Nabin Åstrand, Ove Alexander Høgmoen Rongved, Pål Winberg, Jan-Olof Sylte, Ingebrigt |
author_facet | Rahman, Fatema Wushur, Imin Malla, Nabin Åstrand, Ove Alexander Høgmoen Rongved, Pål Winberg, Jan-Olof Sylte, Ingebrigt |
author_sort | Rahman, Fatema |
collection | PubMed |
description | Inhibition of bacterial virulence is believed to be a new treatment option for bacterial infections. In the present study, we tested dipicolylamine (DPA), tripicolylamine (TPA), tris pyridine ethylene diamine (TPED), pyridine and thiophene derivatives as putative inhibitors of the bacterial virulence factors thermolysin (TLN), pseudolysin (PLN) and aureolysin (ALN) and the human zinc metalloproteases, matrix metalloprotease-9 (MMP-9) and matrix metalloprotease-14 (MMP-14). These compounds have nitrogen or sulfur as putative donor atoms for zinc chelation. In general, the compounds showed stronger inhibition of MMP-14 and PLN than of the other enzymes, with K(i) values in the lower μM range. Except for DPA, none of the compounds showed significantly stronger inhibition of the virulence factors than of the human zinc metalloproteases. TPA and Zn230 were the only compounds that inhibited all five zinc metalloproteinases with a K(i) value in the lower μM range. The thiophene compounds gave weak or no inhibition. Docking indicated that some of the compounds coordinated zinc by one oxygen atom from a hydroxyl or carbonyl group, or by oxygen atoms both from a hydroxyl group and a carbonyl group, and not by pyridine nitrogen as in DPA and TPA. |
format | Online Article Text |
id | pubmed-8746695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87466952022-01-11 Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases Rahman, Fatema Wushur, Imin Malla, Nabin Åstrand, Ove Alexander Høgmoen Rongved, Pål Winberg, Jan-Olof Sylte, Ingebrigt Molecules Article Inhibition of bacterial virulence is believed to be a new treatment option for bacterial infections. In the present study, we tested dipicolylamine (DPA), tripicolylamine (TPA), tris pyridine ethylene diamine (TPED), pyridine and thiophene derivatives as putative inhibitors of the bacterial virulence factors thermolysin (TLN), pseudolysin (PLN) and aureolysin (ALN) and the human zinc metalloproteases, matrix metalloprotease-9 (MMP-9) and matrix metalloprotease-14 (MMP-14). These compounds have nitrogen or sulfur as putative donor atoms for zinc chelation. In general, the compounds showed stronger inhibition of MMP-14 and PLN than of the other enzymes, with K(i) values in the lower μM range. Except for DPA, none of the compounds showed significantly stronger inhibition of the virulence factors than of the human zinc metalloproteases. TPA and Zn230 were the only compounds that inhibited all five zinc metalloproteinases with a K(i) value in the lower μM range. The thiophene compounds gave weak or no inhibition. Docking indicated that some of the compounds coordinated zinc by one oxygen atom from a hydroxyl or carbonyl group, or by oxygen atoms both from a hydroxyl group and a carbonyl group, and not by pyridine nitrogen as in DPA and TPA. MDPI 2021-12-22 /pmc/articles/PMC8746695/ /pubmed/35011288 http://dx.doi.org/10.3390/molecules27010056 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rahman, Fatema Wushur, Imin Malla, Nabin Åstrand, Ove Alexander Høgmoen Rongved, Pål Winberg, Jan-Olof Sylte, Ingebrigt Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title | Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title_full | Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title_fullStr | Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title_full_unstemmed | Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title_short | Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases |
title_sort | zinc-chelating compounds as inhibitors of human and bacterial zinc metalloproteases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746695/ https://www.ncbi.nlm.nih.gov/pubmed/35011288 http://dx.doi.org/10.3390/molecules27010056 |
work_keys_str_mv | AT rahmanfatema zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT wushurimin zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT mallanabin zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT astrandovealexanderhøgmoen zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT rongvedpal zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT winbergjanolof zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases AT sylteingebrigt zincchelatingcompoundsasinhibitorsofhumanandbacterialzincmetalloproteases |